Sarah Kathryn Rouan - 30 Jun 2021 Form 4 Insider Report for NAVIDEA BIOPHARMACEUTICALS, INC.

Role
Director
Signature
/s/ Jed A. Latkin for S. Kathryn Rouan, by power of attorney
Issuer symbol
N/A
Transactions as of
30 Jun 2021
Net transactions value
$0
Form type
4
Filing time
07 Jul 2021, 17:46:07 UTC
Next filing
05 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NAVB Common Stock Award $0 +4,892 +37% $0.000000 18,242 30 Jun 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock issued under the Amended and Restated 2014 Stock Incentive Plan in partial payment of quarterly non-employee director fees.